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How to develop a more accurate risk prediction model when 
there are few events
Menelaos Pavlou,1 Gareth Ambler,1 Shaun R Seaman,2 Oliver Guttmann,3 Perry Elliott,4  
Michael King,5 Rumana Z Omar1 
When the number of events is low 
relative to the number of predictors, 
standard regression could produce 
overﬁtted risk models that make 
inaccurate predictions. Use of 
penalised regression may improve the 
accuracy of risk prediction
Risk prediction models that typically use a number of 
predictors based on patient characteristics to predict 
health outcomes are a cornerstone of modern clinical 
medicine.1  Models developed using data with few 
events compared with the number of predictors often 
underperform when applied to new patient cohorts.2 
A key statistical reason for this is “model overfitting.” 
Overfitted models tend to underestimate the proba-
bility of an event in low risk patients and overesti-
mate it in high risk patients, which could affect 
clinical decision making. In this paper, we discuss 
the potential of penalised regression methods to alle-
viate this problem and thus develop more accurate 
prediction models.
Statistical models are often used to predict the 
probability that an individual with a given set of risk 
factors will experience a health outcome, usually 
termed an “event.” These risk prediction models can 
help in clinical decision making and help patients 
make an informed choice regarding their treat-
ment.3-6 Risk models are developed using several risk 
factors typically based on patient characteristics that 
are thought to be associated with the health event of 
interest (box 1). These predictors are usually selected 
on the basis of clinical experience and following a 
literature review. Given patient characteristics, the 
risk model can calculate the probability of a patient 
having the event. However, before a risk model is 
used in clinical practice, the predictive ability of the 
model should be evaluated. This process is known as 
model validation, and involves an assessment of 
 calibration (the agreement between the observed 
outcomes and predictions) and discrimination (the 
model’s ability to discriminate between low and high 
risk patients).2  Typically, the model is validated 
internally (for example, using bootstrapping7 in 
box 2) or externally using patient data not used for 
model development (box 1).
In practice, datasets used in risk model development 
often contain few events compared with the number of 
candidate predictors, particularly when the event of 
interest is rare. An example would be structural failure 
of mechanical heart valves8  and sudden cardiac death 
in patients with hypertrophic cardiomyopathy.6  In such 
situations, use of standard regression methods to 
develop risk models could accurately predict outcomes 
for patients in the dataset used to develop the model, 
but may often perform less well in a new patient group. 
This difference is because the fitted model captures not 
only the underlying clinical associations between the 
outcome and predictors, but also the random variation 
(noise) present in the development dataset. This prob-
lem is called “model overfitting.” An overfitted model 
typically underestimates the probability of an event in 
low risk patients and overestimates it in high risk 
patients.2  This is known as poor calibration and has 
important consequences for clinical decision making. 
For example, overestimation of sudden cardiac death 
risk could lead to the unnecessary recommendation of 
implantable cardioverter defibrillators, exposing 
patients to surgical complications and wasting 
resources.6
This article focuses on ridge and lasso, two popular 
regression methods that can be used to alleviate the 
problem of model overfitting and are recommended in 
the TRIPOD checklist for developing and validating pre-
diction models.9 Their ability to provide more accurate 
predictions than standard methods when there are few 
events is illustrated in two clinical examples.
Sample size calculation for developing risk prediction 
models
When developing a risk model, a rule of thumb based 
on the events per variable (EPV) ratio is often used to 
determine the sample size. The EPV is the number of 
events in the data divided by the number of regression 
coefficients in the risk model. (Note that if variable 
selection is performed, the number of regression 
 coefficients refers to the initial set of predictors, before 
variable selection.) It has been suggested that an EPV of 
10 or more is needed to avoid the problem of overfit-
ting.7 10  For example, a dataset should contain at least 
60 events to fit a risk model with six regression 
Summary pointS
Risk prediction models are used in clinical decision making and are used to help 
patients make an informed choice about their treatment
Model overfitting could arise when the number of events is small compared with the 
number of predictors in the risk model
In an overfitted model, the probability of an event tends to be underestimated in 
low risk patients and overestimated in high risk patients
In datasets with few events, penalised regression methods can provide better 
predictions than standard regression
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 coefficients. When the EPV is smaller than 10, the effect 
of overfitting is pronounced.11
The development of a risk model often begins with a 
systematic review of the literature and consultation 
with clinical experts to identify a set of candidate pre-
dictors. However, even when this procedure is followed, 
an EPV of 10 may be difficult to achieve in studies 
involving few events, and therefore researchers often 
consider ways to reduce the number of predictors before 
developing the model. 
There are two common strategies. The first is uni-
variable screening, where each predictor’s relation 
with the outcome is examined individually and only 
statistically significant predictors are included in the 
risk model. The second strategy is stepwise model 
selection (for example, backwards elimination), 
where predictors that are not statistically significant 
at a prespecified P value are removed in a stepwise 
manner from a model that initially includes all candi-
date predictors. However, both approaches have seri-
ous drawbacks—for example, the predictor selection 
process may not be stable (small changes in the data 
or in the predictor selection process could lead to dif-
ferent predictors being included in the final 
model).7 11-13
Shrinkage methods
Another way to alleviate the problem of model overfit-
ting is to use methods that tend to shrink the regression 
coefficients (towards zero). Shrinking the regression 
coefficients has the effect of moving poorly calibrated 
predicted risks towards the average risk, and could 
assist in making more accurate predictions when the 
model is applied in new patients.11 14
The simplest method is to shrink the regression 
coefficients by a common factor—for example, 20%—
after they have been estimated by standard regression. 
This factor can be chosen using bootstrapping.7 15 
However, this approach does not perform well if the 
EPV is very low,14 and we do not discuss it further. An 
alternative approach, which is the focus of this paper, 
is to incorporate shrinkage as part of the model fitting 
procedure.
Penalised regression
Penalised regression is a flexible shrinkage approach 
that is effective when the EPV is low (<10). It aims to fit 
the same statistical model as standard regression but 
uses a different estimation procedure.
The process of fitting a penalised regression model 
is as follows. Firstly, the form of the risk model (for 
example, logistic or Cox regression for binary and sur-
vival data, respectively) is specified using all candi-
date predictors. Next, the model is fitted to the data to 
estimate the regression coefficients. In standard logis-
tic or Cox regression, the coefficients are estimated 
without imposing any constraints on their values. In 
datasets with few events, the range of the predicted 
risks is too wide as result of overfitting, but this range 
can be reduced by shrinking the regression coeffi-
cients towards zero. Penalised regression achieves 
Box 2: Bootstrap validation
Bootstrap validation may be used when no external cohort of patients is available. 
The aim is to estimate how good the performance of the prediction model developed 
on the development set (the original dataset) would be on a hypothetical set of new 
patients. A bootstrap dataset is an imitation of the original dataset and is constructed 
by the random sampling of patients “with replacement” (that is, a patient can be 
selected more than once) from the original dataset.
Typically, a large number of bootstrap datasets (for example, 200) is created. Each 
dataset acts as a development dataset. In the simplest form of internal validation for 
the performance measure of a calibration slope:
•	The model is fitted to each bootstrap dataset
•	The estimated coefficients are used to obtain predictions for the patients in the 
original dataset
•	These predictions are used to calculate the calibration slope for the fitted model.
The 200 estimates (one estimate for each bootstrap dataset) of the calibration slope 
are then averaged. For other performance measures—for example, the area under the 
receiver operating characteristic (ROC) curve—optimism adjusted measures can be 
obtained using a similar procedure.
Box 1: Development and validation of a risk model with a binary outcome 
Development 
This stage is when information on a binary outcome and predictor variables in a 
patient cohort is obtained, and a risk model is constructed. For illustration, we 
consider here an example outcome and set of predictor variables. 
•	Outcome: mechanical failure of artificial heart valve (yes v no)
•	Predictor variables: sex (score of 1=female), age (years), body surface area (BSA; 
m2), and whether a replacement valve came from a batch with fractures (score of 
1=valve came from batch with fractures)
A risk model relates the risk of a patient experiencing an event to a set of predictors. 
A common choice is the logistic regression model, which takes the form:
•	Patient’s risk of heart failure = exp(patient’s risk score) ÷ (1+exp(patient’s risk 
score))
•	Where patient’s risk score = intercept + (bsex×sex) + (bage×age) + (bBSA×BSA) + 
(bfracture×fracture); 
•	And bsex, bage, bBSA, and bfracture are regression coefficients that describe how a 
patient’s values of the predictor variables affect risk.
The regression coefficients are estimated as those values that optimise the ability of 
the model to predict the outcomes in the patient cohort. This is called “fitting the risk 
model,” and can be achieved using various methods, such as standard logistic 
regression, ridge, or lasso.
Prediction
To predict risk, the fitted risk model is used to calculate a risk score for each patient. 
For example, if the estimated regression coefficients are as follows:
•	bsex = −0.193
•	bage = −0.0497
•	bBSA= 1.344
•	bfracture = 1.261
•	 Intercept = −4.25
The risk score for a 40 year old female patient with a body surface area of 1.7 m2 and 
an artificial valve from a batch with fractures would then be calculated as:
•	− 4.25 + (−0.193×1 (female sex)) + (−0.0497×40 (age; years))  
+ (1.344 × 1.7 (BSA in m2)) + (1.261 × 1 (fracture present in batch)) = −2.89
Therefore, her predicted risk would be:
•	exp(−2.89) ÷ (1+exp(−2.89)) = 5.3%
External validation
For external validation, a completely new cohort of patients with information on the 
same outcome and predictors is studied. The estimated regression coefficients (from 
the development phase) are used to predict the risks for patients in the new cohort. 
The agreement between the predicted risks and observed outcomes is assessed—
that is, the model is validated by evaluating performance measures that assess, for 
example, calibration and discrimination.
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this by placing a constraint on the values of the 
regression coefficients. The penalised regression coef-
ficient estimates are typically smaller than those from 
standard regression. Several penalised methods that 
use  different constraints have been proposed.13 16 17 
We focus on ridge and lasso,14 arguably the two most 
popular shrinkage methods.
Ridge regression
Ridge fits the risk model under the constraint that the 
sum of the squared regression coefficients does not 
exceed a particular threshold.17 18 The threshold is cho-
sen to maximise the model’s predictive ability, using 
cross validation. In cross validation, the dataset is split 
into k groups. The model is fitted to the (k−1) groups 
and validated on the omitted group. This procedure is 
repeated k times, each time omitting a different group.
Lasso regression
Lasso is similar to ridge, but constrains the sum of the 
absolute values of the regression coefficients.16 Unlike 
ridge, lasso can effectively exclude predictors from the 
final model by shrinking their coefficients to exactly 
zero. Both ridge and lasso regression are readily avail-
able in software such as R (for example, package 
“penalized”) and SPSS.
In health research, where a set of prespecified predic-
tors is often available, ridge regression is usually the 
preferred option.14 However, lasso might be preferred if 
a simpler model with fewer predictors (without affect-
ing the predictive ability of the model) is desired, for 
example, to save time or resources by collecting less 
information on patients.
How to detect model overfitting
An overfitted model could be detected through an 
assessment of model calibration using either an inter-
nal validation technique or external validation.7  This 
may be done by dividing the patients into risk groups 
according to their predicted risk, and comparing the 
proportion of patients who experienced the event in 
each group with the average predicted risk in that 
group, using a graph (calibration plot2) or table (which 
leads to the Hosmer-Lemeshow test19). 
Alternatively, the degree of overfitting may be quan-
tified using a simple regression model. For binary out-
comes, the outcomes in the validation data are 
regressed using logistic regression on their predicted 
risk scores (box 1). If the model is well calibrated, the 
estimated slope (or calibration slope) should be close 
to 1, whereas an overfitted model would have a slope 
much less than 1, indicating that low risks are under-
estimated and high risks are overestimated.2
application of penalised regression
The use of ridge and lasso methods can be illustrated 
by using data for 3118 patients with mechanical 
heart valves.8 The event of interest was the mechani-
cal failure of the artificial valve, which occurred in 
only 56 individuals. The candidate predictors in this 
analysis were patient age, sex, BSA, fractures in the 
batch of the valve (no v yes), year of valve manufac-
ture (before 1981 v after 1981), and valve size or posi-
tion modelled using six clinically meaningful 
combinations constructed according to their 
expected levels of risk. A logistic regression model 
was used for illustrative purposes, with 10 coeffi-
cients. The EPV is 56/10=5.6, well below the recom-
mended minimum of 10.
Standard, ridge, and lasso regression were used to 
estimate the regression coefficients shown in the table . 
We also used backwards elimination (with a 15% signif-
icance level14), which excluded the variable sex from 
the model (coefficients not shown).
The ridge and lasso coefficients were reduced com-
pared with those from the standard regression model, 
with the greatest shrinkage applied to the valve size and 
position predictors (45-84% shrinkage for ridge and 
33-68% for lasso). The shrinkage is reflected by the pre-
dicted risks, especially for high risk patients. Consider, 
for example, a female patient aged 20.5 years and with 1.7 
m2 BSA, who had a 31 mm mitral valve manufactured 
after 1981 from a batch without fractured implants. Using 
the estimated coefficients from standard  regression 
Estimates of regression coefficients, calculated by standard regression and penalised methods
Predictors
Regression coefficient estimates*
Descriptive statistics† Standard regression Ridge regression Lasso regression
Intercept — −7.80 −5.97 (23) −6.65 (15)
Sex (female) 1337 (43) −0.24 −0.14 (41) −0.16 (34)
Age (years) 54.1 (10.8) −0.052 −0.047 (11) −0.050 (4)
Body surface area (m2) 1.6 (0.3) 1.98 1.52 (24) 1.75 (12)
Aortic size 23, 27, 29, 31 mm 692 (22) 1.43 0.36 (75) 0.61 (68)
Mitral size 23-27 mm 369 (12) 1.30 0.22 (84) 0.43 (67)
Mitral size 29 mm 611(20) 1.95 0.80 (59) 1.13 (42)
Mitral size 31 mm 656 (21) 2.62 1.38 (47) 1.77 (33)
Mitral size 33 mm 104 (3) 2.58 1.41 (45) 1.73 (33)
Fracture in batch (yes) 1108 (35) 0.59 0.69 (−17) 0.64 (−9)
Date of manufacture (after 1981) 2363 (76) 1.38 1.02 (26) 1.22 (12)
*For ridge and lasso methods, numbers in brackets are percentages and represent the shrinkage compared with the standard regression estimates.
†For descriptive statistics, data are mean (standard deviation) for continuous predictors (age and body surface area), and number (percentages) for 
binary predictors. 
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(table), the risk score for this patient is calculated by the 
following formula:
Risk score = −7.8 (intercept)
+(−0.24×1(female sex)) + (−0.052×20.5(age; years))
+ (1.98×1.7(BSA; m2)) + (2.62 × 1(mitral size 31 mm))
+ (0.589 × 0(no fracture))
+ (1.38×1(date of manufacture after 1981)) = −1.714. 
Therefore, the predicted risk of mechanical failure is:
exp(−1.714) ÷ (1+exp(−1.714)) =
18% (average risk is 1.8%). 
When the estimated coefficients from ridge and lasso 
are used instead, the predicted risks are less extreme: 
12% and 15%, respectively. Figure 1 confirms that there 
are fewer extreme risk scores after applying shrinkage.
The predictive performances of the risk models 
(developed using standard regression, backwards 
elimination, ridge, and lasso) were assessed using 
bootstrap validation (box 2).7 Calibration was assessed 
using the calibration slope and a calibration plot. Dis-
crimination was measured by the commonly used area 
under the ROC curve measure, where a value of 1 suggests 
perfect discrimination and a value of 0.5 suggests no 
 discrimination.
Standard regression produced an overfitted model 
(calibration slope 0.76 (95% confidence interval 0.65 to 
0.99)), whereas the models from ridge and lasso 
demonstrated far better calibration (calibration slopes 
of 1.01 and 0.94, respectively). The calibration plot in 
fig 2 shows the observed proportion of patients who 
experienced the event and the average of their pre-
dicted risks in each of the four groups. Clearly, the 
standard risk model severely overestimates the risk of 
valve fracture for patients at the highest risk, which in 
practice might lead to patients undergoing unneces-
sary valve explant surgery. All three risk models (from 
standard, ridge, and lasso regression) demonstrated 
similar discrimination (all ROC areas 0.80 (95% confi-
dence interval 0.78 to 0.82)). Backwards elimination 
also produced an overfitted model (calibration slope 
0.77) with similar discrimination (ROC area 0.795). 
A second example illustrates the external validation of 
risk models (based on Cox regression) for sudden 
 cardiac death in patients with hypertrophic cardiomy-
opathy (web appendix).
Conclusion
When the number of events is low relative to the 
 number of predictors in the risk model, standard 
regression may produce overfitted risk models that 
make inaccurate predictions. Common approaches to 
reduce the number of predictors in a risk model, such 
as stepwise selection or univariable screening, are 
problematic and should be avoided.7 14  Often the EPV 
can still be small (<10) even after existing knowledge 
has been used to eliminate some of the initial candi-
date predictors. In such cases, it is recommended that 
the use of penalised regression methods be explored. 
Risk models produced using penalised regression 
 generally show improved calibration, and could also 
show improved discrimination.14
Other methods could be more appropriate in some 
situations.13  Notably, there may be scenarios where 
existing evidence (from published risk models, 
meta-analysis, and expert opinion) can be incorporated 
in the estimation procedure. These contributions could 
lead to better predictions than those obtained from 
ridge and lasso.20  21  In this paper, we focused on the 
issue of model overfitting, but small datasets and data-
sets with few events are also susceptible to other prob-
lems, especially when binary predictors with a very low 
(or high) prevalence are present; in such scenarios 
other methods may be more suitable than ridge and 
lasso.22
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